Inovio Pharmaceuticals’ Published Universal Flu Vaccine Data Demonstrates Protective Responses Against All Major, Lethal H1N1 Influenza Viruses From the Last 100 Years in Animal Models
PLYMOUTH MEETING, Pa., Jan. 22, 2018– Inovio Pharmaceuticals, Inc. today announced that Inovio’ s synthetic vaccine approach using a collection of synthetic DNA antigens generated broad protective antibod
Inovio Pharmaceuticals' Published Universal Flu Vaccine Data Demonstrates Protective Responses Against All Major, Lethal H1N1 Influenza Viruses From the Last 100 Years in Animal Models
Source: Virology News